Viral Skin Infections
Key Points
- Common viral skin patterns include herpes zoster, herpes simplex, and COVID-19-associated eruptions.
- Herpes zoster usually follows a unilateral dermatome and does not cross the midline.
- HSV lesions often begin with tingling or itching before clustered vesicles appear.
- Eye or ear-adjacent lesions require urgent escalation because sensory complications can progress quickly.
Pathophysiology
Viral skin infections occur when latent or active viral replication produces inflammatory epidermal and dermal changes. Clinical pattern recognition guides early treatment and complication prevention.
Herpes zoster reflects reactivation of latent varicella-zoster virus in sensory ganglia, producing neuritic pain and a dermatomal vesicular eruption. Herpes simplex virus causes recurrent vesicular outbreaks at oral, facial, genital, or periorificial sites. COVID-19 can trigger inflammatory or vascular-pattern skin findings during systemic infection.
Classification
- Herpes zoster (shingles): Viral prodrome with malaise, fever, and localized burning before painful unilateral dermatomal vesicles.
- HSV-1: Usually oral-facial vesicular outbreaks; can also involve genital skin.
- HSV-2: Most common viral cause of genital herpes outbreaks.
- COVID-19 cutaneous patterns: Itchy maculopapular eruptions, urticarial lesions, petechial patterns, vesicular lesions, and chilblain-like toe discoloration/inflammation.
Nursing Assessment
NCLEX Focus
Identify rash pattern and location first, then screen urgently for sensory-organ risk and secondary infection.
- Assess prodromal symptoms (fever, malaise, localized tingling/burning) before eruption.
- In shingles patterns, verify unilateral dermatomal vesicles that do not cross midline and trend pain severity.
- In HSV patterns, assess grouped vesicles on an erythematous base and pre-eruptive itching/tingling history.
- Escalate lesions involving or approaching the eye or ear because keratitis, vision compromise, or hearing complications may occur.
- In COVID-19 skin findings, document morphology/distribution and correlate with systemic symptom timeline.
- Assess open or excoriated lesions for secondary bacterial-infection cues (increasing erythema, warmth, swelling, purulent drainage).
Diagnostics
- Diagnosis is primarily clinical from lesion morphology and distribution.
- If confirmation is needed in HSV-suspected lesions, obtain viral culture/PCR sample from vesicle fluid per protocol.
- Support safe specimen technique for vesicular lesions by collecting fluid from a freshly unroofed lesion when ordered.
Nursing Interventions
- Administer ordered oral antivirals early in herpes zoster/HSV pathways (for example acyclovir or valacyclovir).
- Apply prescribed topical agents to reduce secondary infection risk in open lesions.
- Provide pain and pruritus support while protecting skin from scratching-related injury.
- Escalate facial, periorbital, auricular, or ocular-adjacent lesions for urgent specialist review.
- For HSV lesions affecting the eye, coordinate ophthalmology referral workflow promptly.
- In COVID-19-associated rashes, notify the provider for worsening or atypical lesions; many eruptions self-resolve, but symptom-targeted topical therapy may be ordered.
High-Risk Pattern
Delayed escalation of zoster or HSV lesions near sensory organs can lead to preventable vision or hearing morbidity.
Pharmacology
| Drug Class | Examples | Key Nursing Considerations |
|---|---|---|
| antiviral-medications | Acyclovir, valacyclovir | Early initiation improves outcomes in zoster and HSV outbreaks. |
| antibiotics | Provider-ordered ointments and systemic options | Used for selected open lesions at risk of secondary bacterial contamination. |
| topical-corticosteroids | Symptom-targeted topical therapy in selected COVID-pattern rashes | Use only when prescribed and monitor skin response. |
Clinical Judgment Application
Clinical Scenario
An older adult presents with severe unilateral burning pain and grouped vesicles along one thoracic dermatome, and a second patient with known COVID-19 develops new toe discoloration and itchy rash.
- Recognize Cues: Dermatomal vesicular pain pattern in one patient and inflammatory toe/rash pattern in another.
- Analyze Cues: First presentation is most consistent with shingles; second suggests COVID-associated cutaneous involvement.
- Prioritize Hypotheses: Prevent neurologic or sensory complications, control symptoms, and monitor for secondary infection.
- Generate Solutions: Initiate ordered antiviral pathway for shingles, perform focused lesion documentation, and escalate high-risk lesion locations.
- Take Action: Administer medications, notify provider of concerning facial/eye/ear distribution, and reinforce skin-protection teaching.
- Evaluate Outcomes: Pain and rash burden decline, no secondary bacterial progression develops, and high-risk complications are avoided.
Related Concepts
- varicella - Primary VZV infection with latent-reactivation link to shingles.
- infectious-and-inflammatory-skin-conditions - Broad integumentary pattern triage and escalation framework.
- scabies - Differential pruritic skin presentation requiring transmission-control distinctions.
- tinea-infection - Fungal lesion differential in itchy or scaling eruptions.
Self-Check
- Which findings most strongly support shingles instead of HSV?
- Why should eye- or ear-adjacent lesions be escalated immediately?
- What assessment findings suggest secondary bacterial infection in viral lesions?